Beneficial effects of erythropoietin in preclinical models of shock and organ failure

Critical Care

Volumn 11, Issue 3, 2007, Pages

  Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE; ZYMOSAN; ERYTHROPOIETIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; ENDOTOXEMIA; ENZYME ACTIVITY; HEMORRHAGIC SHOCK; HUMAN; LOW DRUG DOSE; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; NOTE; OXYGEN TRANSPORT; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; SHOCK; SPINAL CORD INJURY; TREATMENT DURATION; ANIMAL; DISEASE MODEL; DOSE RESPONSE; MOUSE; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; ERYTHROPOIETIN; MICE; MULTIPLE ORGAN FAILURE; SHOCK; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; SPINAL CORD INJURIES; TREATMENT OUTCOME; ZYMOSAN;

EID: 84927714672     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5912     Document Type: Note

References (13)

1. Kao R Xenocostas A Rui T Yu P Huang W Rose J Martin CM Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model Crit Care 2007, 11:R58. 10.1186/cc5920 17509156
2. Sakanaka M Wen TC Matsuda S Masuda S Morishita E Nagao M Sasaki R In vivo evidence that erythropoietin protects neurons from ischemic damage Proc Natl Acad Sci USA 1998, 95:4635-4640. 22542 9539790 10.1073/ pnas.95.8.4635
3. Parsa CJ Matsumoto A Kim J Riel RU Pascal LS Walton GB Thompson RB Petrofski JA Annex BH Stamler JS A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 2003, 112:999-1007. 198525 14523037 10.1172/JCI200318200
4. Sharples EJ Patel N Brown P Stewart K Mota-Philipe H Sheaff M Kieswich J Allen D Harwood S Raftery M Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion J Am Soc Nephrol 2004, 15:2115-2124. 10.1097/01.ASN.0000135059.67385.5D 15284297
5. Sepodes B Maio R Pinto R Sharples E Oliveira P McDonald M Yaqoob M Thiemermann C Mota-Filipe H Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat Transpl Int 2006, 19:919-926. 10.1111/j.1432-2277.2006.00366.x 17018128
6. Sharples EJ Thiemermann C Yaqoob MM Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin Nat Clin Pract Nephrol 2005, 1:87-97. 10.1038/ncpneph0042 16932374
7. Brines M Cerami A Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise Kidney Int 2006, 70:246-250. 10.1038/sj.ki.5001546 16738535
8. Abdelrahman M Sharples EJ McDonald MC Collin M Patel NS Yaqoob MM Thiemermann C Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia Shock 2004, 22:63-69. 10.1097/01.shk.00001276869.21260.9d 15201704
9. Celik M Gokmen N Erbayraktar S Akhisaroglu M Konakc S Ulukus C Genc S Genc K Sagiroglu E Cerami A Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc Natl Acad Sci USA 2002, 99:2258-2263. 122352 11854521 10.1073/pnas.042693799
10. Mitra A Bansal S Wang W Falk S Zolty E Schrier RW Erythropoietin ameliorates renal dysfunction during endotoxaemia Nephrol Dial Transplant 2007. 17438005
11. Cuzzocrea S Mazzon E Di Paola R Patel NS Genovese T Muia C De Sarro A Thiemermann C Erythropoietin reduces the development of experimental inflammatory bowel disease J Pharmacol Exp Ther 2004, 311:1272-1280. 10.1124/jpet.104.073197 15302898
12. Cuzzocrea S Di Paola R Mazzon E Patel NS Genovese T Muia C Crisafulli C Caputi AP Thiemermann C Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice Crit Care Med 2006, 34:1168-1177. 10.1097/01.CCM.0000207346.56477.E8 16484922
13. Silver M Corwin MJ Bazan A Gettinger A Enny C Corwin HL Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial Crit Care Med 2006, 34:2310-2316. 10.1097/ 01.CCM.0000233873.17954.42 16878035